The delivery of a clinical trial to the highest scientific standards can be challenging in today’s complex, high-cost, high-risk clinical trials environment. The Scientific Leadership Model may be the answer.
Following the recent publication of the results of one of the largest obstructive sleep apnea medical device trials (SAVE) ever undertaken, Professor Craig Anderson, will discuss the emergence of scientific leadership as an innovative service addition to a clinical trials design and delivery. Professor Craig Anderson has conducted some of the largest global neurology and blood pressure trials ever undertaken. He is widely considered a world authority on stroke and much of his success has revolved around conducting clinical trials in Asia.
In this webinar, Professor Anderson will discuss the recent success of the SAVE trial, which recruited over 2700 patients globally, with over 63% of those participants coming from China. Professor Anderson will outline many of the opportunities that exist when conducting clinical trials, such as the SAVE trial, in Asia and debunk a lot of the misconceptions that exist for sponsors who have operated in the traditional clinical trial markets of the USA and Europe.
Professor Anderson will:
- Define the Scientific Leadership Model
- Outline how the Scientific Model is implemented in a trial design and through trial delivery.
- Address the benefits and the hurdles of conducting large clinical trials in Asia.
Professor Craig, Anderson, Executive Director, The George Institute, China, Senior Director, Neurological & Mental Health Division
Craig Anderson is Professor of Stroke Medicine and Clinical Neuroscience in the Sydney Medical School at the University of Sydney and the Institute of Neurosciences of Royal Prince Alfred Hospital. Having led several major international stroke studies, Craig is widely acknowledged as a leader in his field.
He was recently awarded the Royal Prince Alfred Research Medal for Excellence in Research. Craig is a member of several specialist societies, an Editor for the Cochrane Stroke Group, and a former President of the Stroke Society of Australasia. He has published widely on the clinicaland epidemiological aspects of stroke, cardiovascular disease and aged care. He is on the Steering Committee for several large-scale research projects.Message Presenter
Emma, Field, Project Manager, George Clinical, A division of The George Institute for Global Health
Emma Field is a Global Project Manager with George Clinical with an MSc in Clinical Research and over 10 years’ experience in the clinical trial industry. Emma has worked within small CRO’s and large Pharmaceutical companies across phase I – III clinical designs. Roles include Data management, Senior Project Management and Operations Management, from initial design concept through to marketing authorisation submissions.
Within George Clinical, Emma leads a team of regional scientific managers within a robust infrastructure of operational support, who collectively manage and coordinate the global Scientific leadership of National Leaders within a large program of Phase III clinical trials. Emma’s role also includes the coordination of the Executive Steering Committee and all sub committees ensuring clear peer to peer communication pathways are established and maintained. Leveraging the framework of National Leaders and Scientific Committee members, coordinated centrally, allows the delivering the George Clinical Scientific model.Message Presenter
Who Should Attend?
Company & Function Types
- Biopharmaceutical / Biologics
- Medical Device companies
- Device, diagnostic, or equipment
- Information technology
- Trial / Site management
‘C’ Level Executives
- Account management
- Clinical monitoring / Investigative site management
- Clinical trial management
- Corporate management
- Creative / Production / Traffic
- Business Development
- R&D/Project management
- Marketing management
- Marketing research
- Media/promotion management
- Product management
George Clinical is a leading independent clinical research organisation (CRO) in Asia with over 200 staff operating in 11 countries. George Clinical provides the full range of clinical trial services to Pharmaceutical, medical device and biotech customers, for all trial phases, registration and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery capability to create a distinctive world-class service. George Clinical’s parent organization, The George Institute for Global Health, is a leader in chronic disease research, with a global network of experts with whom George Clinical engages. George Clinical delivers an operationally supported, internationally recognized scientific leadership service, bringing together an extensive series of investigator networks that allow George Clinical to provide customizable clinical trial excellence from trial design through all aspects of delivery.